NCT04873050

Treatment to Regress to Normoglycemia in Women with a Recent History of GDM

RecruitingPHASE4INTERVENTIONAL

Trial Details

Start: 2022-01-13Est. Completion: 2026-01-01

Enrollment target: 102 participants

Locations

Contact

Non-alcoholic Fatty Liver Disease

The purpose of this study is to assess the safety and efficacy of efimosfermin alfa in the resolution of steatohepatitis…

Chandler, United StatesEst. completion Mar 29, 2028

Type 2 Diabetes Mellitus (T2DM)Obesity (Disorder)OverweightMetabolic Syndrome

The goal of this clinical trial is to learn whether the NutriSteppe mobile application can improve blood sugar control a…

Almaty, KazakhstanEst. completion Nov 2026

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.